Rx Price Increases After Medicare Passage Undermine Law's Intent – AARP
Executive Summary
Increases in drug pricing in the first quarter after enactment of the Medicare Rx law raise a concern that manufacturers are undermining the intent of the law, AARP said
You may also be interested in...
Lipitor, Lovastatin Are “Best Buy” Statins, Consumers Union Says
Pfizer's Lipitor and generic lovastatin are rated "best buy" in the statin class of cholesterol lowering drugs by Consumer Reports publisher Consumers Union
Lipitor, Lovastatin Are “Best Buy” Statins, Consumers Union Says
Pfizer's Lipitor and generic lovastatin are rated "best buy" in the statin class of cholesterol lowering drugs by Consumer Reports publisher Consumers Union
PhRMA Studies Contest AARP Drug Price “Watchdog Report”
Prescription drug prices rose only 0.9% in the first quarter of 2004, not 3.4% as AARP claims, a study of Bureau of Labor Statistics data commissioned by the Pharmaceutical Research & Manufacturers of America says